心肺旁路术后成年人的功能障碍与S-酸盐血红蛋白的下降有关:一个案例系列
Andrew Moyal1, Ryan Nazemian1,2, Edwin Pacheco Colon1,2
1Institute for Transformative Molecular Medicine.
Annals of medicine and surgery (2012)
|May 2, 2024
概括
心肺绕道 (CPB) 降低了S-nitroso血红蛋白 (SNO-Hb),影响功能和重症监护室停留. 维持SNO-Hb可能会改善心脏手术患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管外科心血管外科
- 生理学 生理学 生理学
背景情况:
- 心肺旁路术 (CPB) 后,功能受损是常见的.
- 以前的研究将CPB期间的输血与降低的S-化血红蛋白 (SNO-Hb) 和功能障碍联系起来.
- 独立于输血的CPB程序本身,通过影响SNO-Hb水平,可能会导致损伤.
研究的目的:
- 调查CPB对S-化血红蛋白 (SNO-Hb) 水平的影响.
- 为了确定SNO-Hb水平和CPB后的功能之间的关系.
- 为了探索SNO-Hb,红色素 (EPO) 和重症监护室 (ICU) 住院之间的相关性.
主要方法:
- 在手术前,手术后,以及手术后的第一天,从患者身上采集了血液样本.
- 量化S-素血红蛋白 (SNO-Hb),估计的淋巴细胞过率 (eGFR) 和血红素 (EPO) 度.
- 从医疗记录中提取了额外的结果数据,包括ICU停留.
主要成果:
- 在CPB之后,S-nitroso血红蛋白 (SNO-Hb) 水平显著下降.
- 手术后的SNO-Hb水平与估计的淋巴细胞过率 (eGFR) (R=0.48) 直接相关.
- 血EPO度升高与SNO-Hb (R=-0.53) 和eGFR (R=-0.55) 相反相关;较长的ICU停留与较低的SNO-Hb (R=-0.32) 相对相关.
结论:
- 在CPB后,即使没有输血,也会发生S-nitroso血红蛋白 (SNO-Hb) 降低.
- 降低SNO-Hb水平预测心脏手术患者的功能下降和长时间的ICU停留.
- 旨在保持或增加SNO-Hb的治疗策略可能会改善心脏手术后患者的治疗结果.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.6K
07:27How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
11.4K
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422